Gregory Stephen Smith, President and CEO of Teradyne, Inc., filed a Form 4 on August 18, 2026, reporting the sale of 4,000 shares of Teradyne common stock on August 17, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Shares sold: 4,000 shares of Teradyne common stock disposed of on August 17, 2026
  • Sale price: $425 per share, as reported in the filing
  • Remaining ownership: Smith beneficially owned 112,495.4075 shares directly following the transaction
  • Pre-planned sale: The transaction was made under a 10b5-1 sales plan adopted by Smith on February 12, 2026
  • Roles: Smith serves as both a Director and President and CEO of Teradyne, Inc.
  • Filed by: Ryan E. Driscoll signed as Attorney-in-Fact on August 18, 2026

Smith's Share Disposal at Teradyne Under Pre-Scheduled Plan

According to the filing, Gregory Stephen Smith, President and CEO of Teradyne, Inc. (NASDAQ:TER), disposed of 4,000 shares of common stock on August 17, 2026, at a price of $425 per share. The Form 4 was filed the following day, August 18, 2026, with Ryan E. Driscoll signing as Attorney-in-Fact on behalf of the reporting person.

The filing discloses that the sale was "effected pursuant to a sales plan adopted by the Reporting Person on February 12, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934." The transaction is recorded with transaction code "S," indicating a sale. The filing also notes that a box was checked to indicate the transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Following the reported sale, Smith's direct beneficial ownership in Teradyne common stock stood at 112,495.4075 shares, according to the filing. No derivative securities transactions were reported in Table II of the Form 4. Smith is identified in the filing as both a Director and an Officer of the issuer, holding the title of President and CEO.

What Was Disclosed

The filing reports a single sale of 4,000 shares of Teradyne common stock by President and CEO Gregory Stephen Smith at $425 per share on August 17, 2026, executed under a 10b5-1 plan adopted February 12, 2026, leaving him with 112,495.4075 shares.